iDrugBank

Anti-Arrhythmia Agents

MESHD000889

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Synonyms

  • Agents, Anti-Arrhythmia
  • Anti Arrhythmia Agents
  • Anti-Arrhythmia Drugs
  • Anti Arrhythmia Drugs
  • Drugs, Anti-Arrhythmia
  • Anti-Arrhythmics
  • Anti Arrhythmics
  • Antiarrhythmia Agents
  • Agents, Antiarrhythmia
  • Antiarrhythmia Drugs
  • Drugs, Antiarrhythmia
  • Antiarrhythmic Drugs
  • Drugs, Antiarrhythmic
  • Anti-Arrhythmia Agent
  • Agent, Anti-Arrhythmia
  • Anti Arrhythmia Agent
  • Anti-Arrhythmia Drug
  • Anti Arrhythmia Drug
  • Drug, Anti-Arrhythmia
  • Antiarrhythmia Agent
  • Agent, Antiarrhythmia
  • Antiarrhythmia Drug
  • Drug, Antiarrhythmia
  • Anti-Arrhythmic
  • Anti Arrhythmic
  • Antiarrhythmic Drug
  • Drug, Antiarrhythmic
  • Antifibrillatory Agents
  • Agents, Antifibrillatory
  • Antifibrillatory Agent
  • Agent, Antifibrillatory
  • Cardiac Depressants
  • Depressants, Cardiac
  • Myocardial Depressants
  • Depressants, Myocardial
  • Cardiac Depressant
  • Depressant, Cardiac
  • Myocardial Depressant
  • Depressant, Myocardial

Source last updated 2026-05-24T15:28:18.691Z